SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-370636
Filing Date
2021-12-30
Accepted
2021-12-30 16:31:00
Documents
2
Group Members
APEIRON PRESIGHT CAPITAL FUND II, L.P.CHRISTIAN ANGERMAYERFABIAN HANSENPRESIGHT CAPITAL MANAGEMENT I, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D d165777dsc13d.htm SC 13D 121171
2 EX-99.1 d165777dex991.htm EX-99.1 6134
  Complete submission text file 0001193125-21-370636.txt   128952
Mailing Address 31 DALGLEISH STREET THEBARTON C3 5031
Business Address 31 DALGLEISH STREET THEBARTON C3 5031 61 8 8354 6107
BIONOMICS LIMITED/FI (Subject) CIK: 0001191070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3
Type: SC 13D | Act: 34 | File No.: 005-93208 | Film No.: 211533193
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Filed by) CIK: 0001845711 (see all company filings)

IRS No.: 000000000 | State of Incorp.: O1 | Fiscal Year End: 1231
Type: SC 13D